Details for Patent: 10,814,001
✉ Email this page to a colleague
Which drugs does patent 10,814,001 protect, and when does it expire?
Patent 10,814,001 protects UPNEEQ and is included in one NDA.
This patent has twenty-one patent family members in sixteen countries.
Summary for Patent: 10,814,001
Title: | Oxymetazoline compositions |
Abstract: | The present disclosure is directed to compositions comprising oxymetazoline and methods of stabilizing oxymetazoline compositions for long term storage. |
Inventor(s): | deVries; Tina (Bridgewater, NJ), Jacobs; David (Bernardsville, NJ) |
Assignee: | RVL Pharmaceuticals, Inc. (Bridgewater, NJ) |
Application Number: | 16/715,998 |
Patent Claim Types: see list of patent claims | Formulation; Compound; | More… ↓ |
Drugs Protected by US Patent 10,814,001
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rvl Pharms | UPNEEQ | oxymetazoline hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 212520-001 | Jul 8, 2020 | RX | Yes | Yes | 10,814,001 | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,814,001
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2020268329 | ⤷ Subscribe | |||
Brazil | 112021022404 | ⤷ Subscribe | |||
Canada | 3139443 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |